Results 161 to 170 of about 2,288 (193)
Some of the next articles are maybe not open access.

Related searches:

D91-06 Training of Neutrophils to Protect From Lethal Infection by Pseudomonas aeruginosa

American Journal of Respiratory and Critical Care Medicine
Abstract Rationale Pseudomonas aeruginosa (PA) is commonly associated with hospital-acquired (nosocomial) pneumonia. Despite access to new antibiotics, multidrug resistance to PA has doubled in recent years causing an urgent need for alternative strategies to boost host defense.
G Kitsios
exaly   +2 more sources

D91-09 The Role of Stem Cell Factor in ILC2 Activation During RSV Infection

American Journal of Respiratory and Critical Care Medicine
Abstract Rationale Respiratory syncytial virus (RSV) is the primary cause of bronchiolitis in children worldwide. Severe RSV infection is associated with childhood wheezing, increased asthma risk, and long-term impairment of lung function. Adults over 60 years are also susceptible to severe RSV
W Fonseca, N W Lukacs
exaly   +2 more sources

D91-07 Excessive Immune and Inflammatory Activation in Primary Ciliary Dyskinesia: Association With Bronchiectasis in Children

American Journal of Respiratory and Critical Care Medicine
Abstract Background and Objectives Primary ciliary dyskinesia (PCD) frequently leads to bronchiectasis in children, significantly impacting prognosis, yet the underlying mechanisms remain unclear. This study investigates risk factors for bronchiectasis in PCD children.
D Lu, W Yang, L Chen, H Liu
exaly   +2 more sources

D91-01 Elevated Serum IgE Independently Predicts Severe Exacerbations in Non-Eosinophilic Bronchiectasis

American Journal of Respiratory and Critical Care Medicine
Abstract Rationale The role of type 2 inflammation in bronchiectasis remains incompletely understood. Serum immunoglobulin E (IgE) and blood eosinophils are often considered overlapping biomarkers, yet their independent prognostic significance has not been delineated.
T -W Kao   +4 more
exaly   +2 more sources

D91-04 Comparative Efficacy of Novel Dipeptidyl Peptidase 1 Inhibitors for Patients With Bronchiectasis: A Network Meta-Analysis

American Journal of Respiratory and Critical Care Medicine
Abstract Background Bronchiectasis is a chronic respiratory disease characterized by recurrent exacerbations. Dipeptidyl peptidase 1(DPP-1) inhibitors, such as brensocatib and HSK31858, represent a novel therapeutic class targeting neutrophil-mediated inflammation.
A Mansour
exaly   +2 more sources

Home - About - Disclaimer - Privacy